As business angel, our investment decision is looking for high risk/reward level where Venture Capital investors would follow in the next 2 to 4 years. We have a very logical rationale behind our investment evaluating options and inflexion points based on weak signals convergence in field we understand very well. When one our focus fields show traction, it is also our role to educate early stage investors on the opportunity and acceleration.
At the convergence of patient wellness empowerment and reducing painkiller addiction
At the convergence of environment footprint and microsatellites management
At the convergence of consumer alternative diet shift and synthetic biology protein production